Heading Towards a Possible Rebirth of the Induced Renal Cell Carcinoma Models?

by Clarisse R. Mazzola, Domenico Ribatti
Published 2020-03-01

Linac-based SBRT for local recurrent prostate cancer after previous radiotherapy

by F. Cuccia, L. Nicosia, R. Mazzola, V. Figlia, N. Giaj-Levra, F. Ricchetti, M. Rigo, C. Vitale, S. Corradini, R. Ruggieri, F. Alongi
Published 2020-11-01

Geriatric assessment tools and preliminary patient-reported outcomes in a cohort of elderly patients treated with 1.5T MR-guided and daily adapted abdominal-pelvic SBRT

by R. Mazzola, V. Figlia, M. Rigo, F. Cuccia, L. Nicosia, N. Giaj-Levra, F. Ricchetti, C. Vitale, A. De Simone, G. Sicignano, S. Naccarato, R. Ruggieri, F. Alongi
Published 2020-11-01

Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative...

by R. Mazzola, G. Francolini, L. Triggiani, G. Napoli, F. Cuccia, L. Nicosia, N. Giaj-Levra, V. Figlia, F. Ricchetti, M. Rigo, C. Vitale, S.M. Magrini, L. Livi, M. Salgarello, F. Alongi
Published 2020-11-01

MR-guidance in clinical reality: current treatment challenges and future perspectives

by S. Corradini, F. Alongi, N. Andratschke, C. Belka, L. Boldrini, F. Cellini, J. Debus, M. Guckenberger, J. Hörner-Rieber, F. J. Lagerwaard, R. Mazzola, M. A. Palacios, M. E. P. Philippens, C. P. J. Raaijmakers, C. H. J. Terhaard, V. Valentini, M. Niyazi
Published 2019-06-01